Latest News and Press Releases
Want to stay updated on the latest news?
-
ROUYN-NORANDA, Québec, 20 août 2019 (GLOBE NEWSWIRE) -- MINES INDÉPENDANTES CHIBOUGAMAU INC. (CBG-V – Bourse de Croissance TSX au Canada, CLL1 – Bourses de Francfort, Stuttgart et Lang...
-
ROUYN-NORANDA, Québec, Aug. 20, 2019 (GLOBE NEWSWIRE) -- Chibougamau Independent Mines Inc. (CBG-TSX-V in Canada, CLL1-Frankfurt, Stuttgart and Lang & Schwarz Stock Exchanges in Germany,...
-
Umsatz aus Cresemba® und Zevtera® um 91 % auf CHF 53 Mio. gesteigertBetriebsergebnis um 35 % verbessertErweiterung des klinischen Untersuchungsprogramms für Derazantinib auf Urothelkarzinome in...
-
Revenue from Cresemba® and Zevtera® increased by 91% to CHF 53 millionOperating result improved by 35%Expansion of derazantinib clinical program into urothelial cancer with immunotherapy...
-
VANCOUVER, British Columbia, Aug. 19, 2019 (GLOBE NEWSWIRE) -- NewLeaf Brands Inc. (CSE:NLB) (OTC: NLBIF) (FSE:0NF) (“NewLeaf Brands” or the “Company”) is pleased to announce that the Company has...
-
VANCOUVER, British Columbia, Aug. 13, 2019 (GLOBE NEWSWIRE) -- NewLeaf Brands Inc. (CSE:NLB) (OTC: NLBIF) (FSE:0NF) (“NewLeaf Brands” or the “Company”) is pleased to announce that it has signed the...
-
Basel, 13. August 2019 – Basilea Pharmaceutica AG (SIX: BSLN) gab heute die Initiierung der FIDES-02 genannten Phase-1/2-Studie mit dem Pan-Fibroblasten-Wachstumsfaktorrezeptor (engl. FGFR)...
-
Basel, Switzerland, August 13, 2019 – Basilea Pharmaceutica Ltd. (SIX: BSLN) announced today that it has initiated the phase 1/2 FIDES-02 study with the pan-fibroblast growth factor receptor (FGFR)...
-
ROUYN-NORANDA, Québec, 08 août 2019 (GLOBE NEWSWIRE) -- MINES INDÉPENDANTES CHIBOUGAMAU INC. (CBG-V – Bourse de Croissance TSX au Canada, CLL1 – Bourses de Francfort, Stuttgart et Lang...
-
ROUYN-NORANDA, Quebec, Aug. 08, 2019 (GLOBE NEWSWIRE) -- Chibougamau Independent Mines Inc. (CBG-TSX-V in Canada, CLL1-Frankfurt, Stuttgart and Lang & Schwarz Stock Exchanges in Germany,...